143 related articles for article (PubMed ID: 36939018)
1. Whole exome sequencing and rare variant association study to identify genetic modifiers,
Hantaweepant C; Suktitipat B; Pithukpakorn M; Chinthammitr Y; Limwongse C; Tansiri N; Sawatnatee S; Takpradit C; Rotchanapanya W; Pongudom S; Charoenprasert K; Paiboonsukwong K; Thamprasert W; Nolwachai N; Rattanasawat W; Sae-Aeng B; Khorwanichakij N; Saetow P; Saengboon S; Kamjornpreecha K; Pholmoo W; Dujjawan B; Siritanaratkul N
Hematology; 2023 Dec; 28(1):2187155. PubMed ID: 36939018
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β
Khamphikham P; Sripichai O; Munkongdee T; Fucharoen S; Tongsima S; Smith DR
Int J Hematol; 2018 Mar; 107(3):297-310. PubMed ID: 29067594
[TBL] [Abstract][Full Text] [Related]
3.
Tamaddoni A; Khabaz Astaneh S; Tabaripour R; Akhavan-Niaki H
Hemoglobin; 2019 Jan; 43(1):12-17. PubMed ID: 30747024
[TBL] [Abstract][Full Text] [Related]
4. A new Krüppel-like factor 1 mutation (c.947G > A or p.C316Y) in humans causes β-thalassemia minor.
Nitta T; Kawano F; Yamashiro Y; Takagi F; Murata T; Tanaka T; Ferania M; Adhiyanto C; Hattori Y
Hemoglobin; 2015; 39(2):121-6. PubMed ID: 25690802
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β-thalassemia major.
Fanis P; Kousiappa I; Phylactides M; Kyrri A; Hadjigavriel M; Christou S; Sitarou M; Kleanthous M
Hum Mutat; 2019 Oct; 40(10):1768-1780. PubMed ID: 31115947
[TBL] [Abstract][Full Text] [Related]
6. A Case of Hereditary Spherocytosis Caused by a Novel Homozygous Mutation in the
Yang K; Ren Q; Wu Y; Zhou Y; Yin X
Hemoglobin; 2019 Mar; 43(2):140-144. PubMed ID: 31190573
[TBL] [Abstract][Full Text] [Related]
7. Nine known and five novel mutations in the erythroid transcription factor KLF1 gene and phenotypic expression of fetal hemoglobin in hemoglobin E disorder.
Tepakhan W; Yamsri S; Sanchaisuriya K; Fucharoen G; Xu X; Fucharoen S
Blood Cells Mol Dis; 2016 Jul; 59():85-91. PubMed ID: 27282573
[TBL] [Abstract][Full Text] [Related]
8. A
Xie XM; Liu YN; Li J; Jiang F; Li DZ
Hemoglobin; 2019 Mar; 43(2):137-139. PubMed ID: 31111750
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.
Chen W; Zhang X; Shang X; Cai R; Li L; Zhou T; Sun M; Xiong F; Xu X
BMC Med Genet; 2010 Feb; 11():31. PubMed ID: 20181291
[TBL] [Abstract][Full Text] [Related]
10. Hyperhaemolysis in a pregnant woman with a homozygous β
Jiwu L; Manna S; Lai M; Ying Z; Yanhui L
Mol Genet Genomic Med; 2021 Jul; 9(7):e1696. PubMed ID: 33960744
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characterization and Hematological Aspects of Hb E-Myanmar [β26(B8)Glu→Lys and β65(E9)Lys→Asn,
Satthakarn S; Boonmee S; Panyasai S
Hemoglobin; 2020 Nov; 44(6):385-390. PubMed ID: 33222574
[TBL] [Abstract][Full Text] [Related]
12. Molecular Understanding of Non-Transfusion-Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia in Northeast Thailand.
Yamsri S; Pakdee N; Fucharoen G; Sanchaisuriya K; Fucharoen S
Acta Haematol; 2016; 136(4):233-239. PubMed ID: 27710960
[TBL] [Abstract][Full Text] [Related]
13. Clinical and hematological features of codon 17, A-T mutation of beta-thalassemia in Thai patients.
Laosombat V; Wongchanchailert M; Sattayasevana B; Wiriyasateinkul A; Fucharoen S
Eur J Haematol; 2001 Feb; 66(2):126-9. PubMed ID: 11168520
[TBL] [Abstract][Full Text] [Related]
14. Mutation screening of the Krüppel-like factor 1 gene using single-strand conformational polymorphism in a cohort of Iranian β-thalassemia patients.
Zaker-Kandjani B; Namdar-Aligoodarzi P; Azarkeivan A; Najmabadi H; Banan M
Hemoglobin; 2015; 39(1):24-9. PubMed ID: 25583416
[TBL] [Abstract][Full Text] [Related]
15. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia.
Liu D; Zhang X; Yu L; Cai R; Ma X; Zheng C; Zhou Y; Liu Q; Wei X; Lin L; Yan T; Huang J; Mohandas N; An X; Xu X
Blood; 2014 Jul; 124(5):803-11. PubMed ID: 24829204
[TBL] [Abstract][Full Text] [Related]
16. Essential genetic modifiers and their measurable impact in a community-recruited population analysis for non-severe hemoglobin E/β-thalassemia prenatal genetic counseling.
Wong P; Chitsobhak T; Jittasathian S; Sirichantharawat C; Cherdchoo N; Prangcharoen W; Jongautchariyakul P; Jampachaisri K; Tapprom A; Deoisares R; Chumnumsiriwath P
Blood Cells Mol Dis; 2023 Nov; 103():102765. PubMed ID: 37353362
[TBL] [Abstract][Full Text] [Related]
17. Thalassemia and erythroid transcription factor
Srivorakun H; Thawinan W; Fucharoen G; Sanchaisuriya K; Fucharoen S
Arch Med Sci; 2022; 18(1):112-120. PubMed ID: 35154532
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of thalassemia intermedia associated with HPFH-6/beta-thalassemia and HPFH-6/Hb E in Thai patients.
Fucharoen S; Fucharoen G; Sanchaisuriya K; Surapot S
Acta Haematol; 2002; 108(3):157-61. PubMed ID: 12373089
[TBL] [Abstract][Full Text] [Related]
19. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
Charoenkwan P; Teerachaimahit P; Sanguansermsri T
Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
[TBL] [Abstract][Full Text] [Related]
20. Study of Clinical, Hematological and Molecular Characteristics of Patients of Thalassemia and Hemoglobinopathies in Tertiary Care Hospital.
Kumar A; Gupta DK; Saluja S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
